World Equity Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-754
Closed -$266K 442
2023
Q1
$266K Buy
+754
New +$102K 0.04% 403

Other funds holding LABU

World Equity Group's LABU Position: Q2 2023 in Review

World Equity Group sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 754 shares — an estimated $266K sold.

World Equity Group first reported a position in LABU in Q1 2023 and held it in 1 quarter. The position peaked at $266K in Q1 2023. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

  • World Equity Group reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
  • World Equity Group sold 754 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $266K.
  • World Equity Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and held it in 1 quarter.
  • World Equity Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $266K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on World Equity Group's 13F filing for Q2 2023, filed 26 Aug 2024.